,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
378,.,.,HGMD|OMIM,.,.,AX079,615541,"Mental retardation, autosomal recessive 39","1.$$$mimNumber,615541###prefix,####preferredTitle,MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39###inheritance,Autosomal recessive ###growthHeight,Short stature ###headAndNeckHead,Microcephaly (-3 to -4 SD) ###headAndNeckFace,Sloping forehead ###headAndNeckEars,Anteverted ears ;###headAndNeckEars,Large ears ###headAndNeckEyes,Deep-set eyes ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Synophrys ###headAndNeckNose,Prominent nose ###headAndNeckTeeth,Malposition of the teeth ###skeletalSpine,Kyphoscoliosis ###neurologicCentralNervousSystem,Delayed psychomotor development ;###neurologicCentralNervousSystem,Mental retardation, moderate to severe ;###neurologicCentralNervousSystem,Speech delay, severe ###neurologicBehavioralPsychiatricManifestations,Hyperactivity ;###neurologicBehavioralPsychiatricManifestations,Aggression ;###neurologicBehavioralPsychiatricManifestations,Stereotyped behavior ###immunology,Decreased circulating naive T cells (1 family) ###miscellaneous,Onset in infancy ;###miscellaneous,Dysmorphic facial features reported in 1 family ;###miscellaneous,Two unrelated families have been reported (last curated November 2013) ###molecularBasis,Caused by mutation in the TELO2-interacting protein 2 gene (TTI2, )",https://www.omim.org/entry/615541,.,Autosomal recessive,Het,8,33361280,C,T,.,.,PASS,0/1:27:50,54.0,",,t,t.t.t.tT,tT,,TT,tTtT.ttt.,,T.,,TT,t.TT.T.,",synonymous_variant;synonymous_variant;synonymous_variant,TTI2,80185,.,NM_001265581.1(TTI2):c.1101G>A(p.Pro367=);NM_001102401.2(TTI2):c.1101G>A(p.Pro367=);NM_025115.3(TTI2):c.1101G>A(p.Pro367=),NM_001102401.2,exon5(8);exon5(8);exon4(7),.;.;.,0.002,0.0086,189,0.015,0.0171,0.0004,0.0145,0.0006,0,7,0.00085,29,2020,0.017,.,.,http://exac.broadinstitute.org/variant/8-33361280-C-T,-0.18,15.4,7,0.0,http://exac.broadinstitute.org/gene/ENSG00000129696,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs17850186,.,.,.,.,.,.,.,.,.,.,.,.,"NM_001102401.2(TTI2):c.1100C>T(p.P367L),DM,Intellectual disability,21937992",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,65,0,AX079
536,.,.,HGMD|OMIM|novel|possible_comhet,.,.,AX079,114480;612555;605724;613029;155255;613347;176807;194070,"Breast cancer, male, susceptibility to;Breast-ovarian cancer, familial, 2;Fanconi anemia, complementation group D1;Glioblastoma 3;Medulloblastoma;Pancreatic cancer 2;Prostate cancer;Wilms tumor","1.$$$mimNumber,114480###prefix,####preferredTitle,BREAST CANCER###inheritance,Autosomal dominant ###neoplasia,Breast carcinoma ###miscellaneous,Genetic heterogeneity ###molecularBasis,Caused by mutation in the breast cancer type 1 gene (BRCA1, );###molecularBasis,Caused by mutation in the breast cancer type 2 gene (BRCA2, );###molecularBasis,Caused by mutation in the solute carrier family 22, member 1-like gene (SLC22A1L, );###molecularBasis,Caused by mutation in the tumor protein p53 gene (TP53, );###molecularBasis,Caused by mutation in the BRCA1-associated C-terminal helicase 1 gene (BRIP1, );###molecularBasis,Caused by mutation in the homolog of the S. cerevisiae RAD51A gene (RAD51A, );###molecularBasis,Susceptibility conferred by mutation in the homolog of the S. pombe checkpoint kinase 2 gene (CHEK2, ) 2.$$$mimNumber,612555###prefix,####preferredTitle,BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2###inheritance,Autosomal dominant ###neoplasia,Breast cancer ;###neoplasia,Ovarian cancer ###miscellaneous,Mutation carriers have an increased risk of developing breast and/or ovarian cancer at an earlier age ;###miscellaneous,Lifetime risk of breast cancer in mutation carriers is 60 to 85% ;###miscellaneous,Lifetime risk of ovarian cancer in mutation carriers is 10 to 20% ;###miscellaneous,Lifetime risk of breast cancer in male mutation carriers in 6% ;###miscellaneous,Increased risk of bilateral breast cancer ###molecularBasis,Susceptibility conferred by mutation in the breast cancer 2 gene (BRCA2, ) 3.$$$mimNumber,605724###prefix,####preferredTitle,FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthOther,Intrauterine growth retardation ;###growthOther,Failure to thrive ###headAndNeckHead,Microcephaly ###headAndNeckFace,Dysmorphic facial features, nonspecific (in some patients) ###cardiovascularHeart,Cardiac defects (in some patients) ###abdomenGastrointestinal,Imperforate anus ###skeletalHands,Hypoplastic thumbs ;###skeletalHands,Abnormal thumbs ###skinNailsHairSkin,Cafe au lait spots ###hematology,Bone marrow failure ###neoplasia,Increased susceptibility to leukemia ;###neoplasia,Increased susceptibility to solid cancers ###laboratoryAbnormalities,Multiple chromosomal breaks ;###laboratoryAbnormalities,Chromosomal breakage induced by diepoxybutane (DEB), and mitomycin C ###miscellaneous,Onset in infancy or early childhood ;###miscellaneous,Extreme sensitivity to chemotherapy ###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, ) 4.$$$mimNumber,613029###prefix,####preferredTitle,GLIOMA SUSCEPTIBILITY 3; GLM3###inheritance,Autosomal recessive ###neoplasia,Brain tumors, multiple types ;###neoplasia,Glioblastoma ;###neoplasia,Medulloblastoma ;###neoplasia,Astrocytoma ###molecularBasis,Susceptibility conferred by mutation in the BRCA2 gene (BRCA2, ) 5.$$$mimNumber,155255###prefix,####preferredTitle,MEDULLOBLASTOMA; MDB###inheritance,Somatic ;###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ###neoplasia,Medulloblastoma ###laboratoryAbnormalities,Isochromosome 17q frequent in cytogenetic studies;###laboratoryAbnormalities,Loss of heterozygosity for 17p sequences in 45% of medulloblastomas###miscellaneous,Incomplete penetrance ###molecularBasis,Caused by mutation in the suppressor of fused gene (SUFU, );###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, );###molecularBasis,Caused by somatic mutation in the catenin beta 1 gene (CTNNB1, );###molecularBasis,Caused by somatic mutation in the homolog of Drosophila patched 2 gene (PTCH2, ) 6.$$$mimNumber,194070###prefix,####preferredTitle,WILMS TUMOR 1; WT1###inheritance,Autosomal dominant ;###inheritance,Somatic mutation ###genitourinaryKidneys,Nephroblastoma ###neoplasia,Nephroblastoma ###miscellaneous,Majority of Wilms tumors are sporadic ;###miscellaneous,Onset between 2-5 years ;###miscellaneous,Rare adult cases reported ;###miscellaneous,5-10% of all Wilms tumor are bilateral ;###miscellaneous,21% of hereditary Wilms tumor are bilateral ;###miscellaneous,Associated with several congenital malformation syndromes (WAGR , abnormal urogenital development syndromes);###miscellaneous,Two-step mutation hypothesis (germline mutation followed by somatic mutation or two sequential somatic mutations) ;###miscellaneous,Loss of tumor suppressor gene ;###miscellaneous,Genetic heterogeneity ;###miscellaneous,Associated with several loci on chromosomes 11p15 (WT2, ).###molecularBasis,Caused by mutation in the WT1 gene (WT1, );###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, )",https://www.omim.org/entry/114480;https://www.omim.org/entry/612555;https://www.omim.org/entry/605724;https://www.omim.org/entry/613029;https://www.omim.org/entry/155255;https://www.omim.org/entry/613347;https://www.omim.org/entry/176807;https://www.omim.org/entry/194070,.,"Autosomal dominant;Autosomal recessive;Autosomal recessive, Autosomal dominant;Autosomal dominant, Somatic mutation",Het,13,32903634,G,A,.,.,PASS,0/1:19:52,36.54,"A.a,,,,,.A.AA..,..A,,.,.Aaa,a,a,,aaAa,Aa,,,aa..,A,,.",splice_region_variant,BRCA2,675,.,NM_000059.3(BRCA2):c.681+5G>A,NM_000059.3,intron8(26),.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,-4.71,69.8,36,0.0,http://exac.broadinstitute.org/gene/ENSG00000139618,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"NM_000059.3(BRCA2):c.681+4A>G,DM?,Breast cancer,22762150",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"brain development (GO:0007420)|cell aging (GO:0007569)|centrosome duplication (GO:0051298)|cytokinesis (GO:0000910)|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|DNA repair (GO:0006281)|double-strand break repair (GO:0006302)|double-strand break repair via homologous recombination (GO:0000724)|female gonad development (GO:0008585)|hemopoiesis (GO:0030097)|histone H3 acetylation (GO:0043966)|histone H4 acetylation (GO:0043967)|inner cell mass cell proliferation (GO:0001833)|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)|male meiosis I (GO:0007141)|negative regulation of mammary gland epithelial cell proliferation (GO:0033600)|nucleotide-excision repair (GO:0006289)|oocyte maturation (GO:0001556)|positive regulation of mitotic cell cycle (GO:0045931)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cytokinesis (GO:0032465)|replication fork protection (GO:0048478)|response to gamma radiation (GO:0010332)|response to UV-C (GO:0010225)|response to X-ray (GO:0010165)|spermatogenesis (GO:0007283)",BRCA2-MAGE-D1 complex (GO:0033593)|centrosome (GO:0005813)|cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|protein complex (GO:0043234)|secretory granule (GO:0030141),gamma-tubulin binding (GO:0043015)|H3 histone acetyltransferase activity (GO:0010484)|H4 histone acetyltransferase activity (GO:0010485)|protease binding (GO:0002020)|single-stranded DNA binding (GO:0003697),.,.,.,.,88,1,AX079
537,.,.,HGMD|OMIM|possible_comhet,.,.,AX079,114480;612555;605724;613029;155255;613347;176807;194070,"Breast cancer, male, susceptibility to;Breast-ovarian cancer, familial, 2;Fanconi anemia, complementation group D1;Glioblastoma 3;Medulloblastoma;Pancreatic cancer 2;Prostate cancer;Wilms tumor","1.$$$mimNumber,114480###prefix,####preferredTitle,BREAST CANCER###inheritance,Autosomal dominant ###neoplasia,Breast carcinoma ###miscellaneous,Genetic heterogeneity ###molecularBasis,Caused by mutation in the breast cancer type 1 gene (BRCA1, );###molecularBasis,Caused by mutation in the breast cancer type 2 gene (BRCA2, );###molecularBasis,Caused by mutation in the solute carrier family 22, member 1-like gene (SLC22A1L, );###molecularBasis,Caused by mutation in the tumor protein p53 gene (TP53, );###molecularBasis,Caused by mutation in the BRCA1-associated C-terminal helicase 1 gene (BRIP1, );###molecularBasis,Caused by mutation in the homolog of the S. cerevisiae RAD51A gene (RAD51A, );###molecularBasis,Susceptibility conferred by mutation in the homolog of the S. pombe checkpoint kinase 2 gene (CHEK2, ) 2.$$$mimNumber,612555###prefix,####preferredTitle,BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2###inheritance,Autosomal dominant ###neoplasia,Breast cancer ;###neoplasia,Ovarian cancer ###miscellaneous,Mutation carriers have an increased risk of developing breast and/or ovarian cancer at an earlier age ;###miscellaneous,Lifetime risk of breast cancer in mutation carriers is 60 to 85% ;###miscellaneous,Lifetime risk of ovarian cancer in mutation carriers is 10 to 20% ;###miscellaneous,Lifetime risk of breast cancer in male mutation carriers in 6% ;###miscellaneous,Increased risk of bilateral breast cancer ###molecularBasis,Susceptibility conferred by mutation in the breast cancer 2 gene (BRCA2, ) 3.$$$mimNumber,605724###prefix,####preferredTitle,FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthOther,Intrauterine growth retardation ;###growthOther,Failure to thrive ###headAndNeckHead,Microcephaly ###headAndNeckFace,Dysmorphic facial features, nonspecific (in some patients) ###cardiovascularHeart,Cardiac defects (in some patients) ###abdomenGastrointestinal,Imperforate anus ###skeletalHands,Hypoplastic thumbs ;###skeletalHands,Abnormal thumbs ###skinNailsHairSkin,Cafe au lait spots ###hematology,Bone marrow failure ###neoplasia,Increased susceptibility to leukemia ;###neoplasia,Increased susceptibility to solid cancers ###laboratoryAbnormalities,Multiple chromosomal breaks ;###laboratoryAbnormalities,Chromosomal breakage induced by diepoxybutane (DEB), and mitomycin C ###miscellaneous,Onset in infancy or early childhood ;###miscellaneous,Extreme sensitivity to chemotherapy ###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, ) 4.$$$mimNumber,613029###prefix,####preferredTitle,GLIOMA SUSCEPTIBILITY 3; GLM3###inheritance,Autosomal recessive ###neoplasia,Brain tumors, multiple types ;###neoplasia,Glioblastoma ;###neoplasia,Medulloblastoma ;###neoplasia,Astrocytoma ###molecularBasis,Susceptibility conferred by mutation in the BRCA2 gene (BRCA2, ) 5.$$$mimNumber,155255###prefix,####preferredTitle,MEDULLOBLASTOMA; MDB###inheritance,Somatic ;###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ###neoplasia,Medulloblastoma ###laboratoryAbnormalities,Isochromosome 17q frequent in cytogenetic studies;###laboratoryAbnormalities,Loss of heterozygosity for 17p sequences in 45% of medulloblastomas###miscellaneous,Incomplete penetrance ###molecularBasis,Caused by mutation in the suppressor of fused gene (SUFU, );###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, );###molecularBasis,Caused by somatic mutation in the catenin beta 1 gene (CTNNB1, );###molecularBasis,Caused by somatic mutation in the homolog of Drosophila patched 2 gene (PTCH2, ) 6.$$$mimNumber,194070###prefix,####preferredTitle,WILMS TUMOR 1; WT1###inheritance,Autosomal dominant ;###inheritance,Somatic mutation ###genitourinaryKidneys,Nephroblastoma ###neoplasia,Nephroblastoma ###miscellaneous,Majority of Wilms tumors are sporadic ;###miscellaneous,Onset between 2-5 years ;###miscellaneous,Rare adult cases reported ;###miscellaneous,5-10% of all Wilms tumor are bilateral ;###miscellaneous,21% of hereditary Wilms tumor are bilateral ;###miscellaneous,Associated with several congenital malformation syndromes (WAGR , abnormal urogenital development syndromes);###miscellaneous,Two-step mutation hypothesis (germline mutation followed by somatic mutation or two sequential somatic mutations) ;###miscellaneous,Loss of tumor suppressor gene ;###miscellaneous,Genetic heterogeneity ;###miscellaneous,Associated with several loci on chromosomes 11p15 (WT2, ).###molecularBasis,Caused by mutation in the WT1 gene (WT1, );###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, )",https://www.omim.org/entry/114480;https://www.omim.org/entry/612555;https://www.omim.org/entry/605724;https://www.omim.org/entry/613029;https://www.omim.org/entry/155255;https://www.omim.org/entry/613347;https://www.omim.org/entry/176807;https://www.omim.org/entry/194070,.,"Autosomal dominant;Autosomal recessive;Autosomal recessive, Autosomal dominant;Autosomal dominant, Somatic mutation",Het,13,32972574,C,T,.,.,PASS,0/1:56:90,62.22,",$,$T,.,TT.,tTTt.TtTTt..,,tt.TTtttt,TTtTTT,TTt.t,,T.Tt.tt,,TT,.,TTT.TtTt,.,.tT,TTTTttt.,",synonymous_variant,BRCA2,675,.,NM_000059.3(BRCA2):c.9924C>T(p.Tyr3308=),NM_000059.3,exon27(27),.,.,.,3,0.00023,7.723e-05,0,0.0004,0,0,0,0,0,10,0.000082,.,.,http://exac.broadinstitute.org/variant/13-32972574-C-T,-4.71,69.8,36,0.0,http://exac.broadinstitute.org/gene/ENSG00000139618,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs4987049,.,.,.,.,NM_000059.3(BRCA2):c.9924C>G(p.Y3308*),DM,Breast and colorectal cancer,17026620,.,.,.,.,"NM_000059.3(BRCA2):c.9925G>T(p.E3309*),DM,Breast cancer,18607349",52917,https://www.ncbi.nlm.nih.gov/clinvar/variation/52917,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"brain development (GO:0007420)|cell aging (GO:0007569)|centrosome duplication (GO:0051298)|cytokinesis (GO:0000910)|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|DNA repair (GO:0006281)|double-strand break repair (GO:0006302)|double-strand break repair via homologous recombination (GO:0000724)|female gonad development (GO:0008585)|hemopoiesis (GO:0030097)|histone H3 acetylation (GO:0043966)|histone H4 acetylation (GO:0043967)|inner cell mass cell proliferation (GO:0001833)|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)|male meiosis I (GO:0007141)|negative regulation of mammary gland epithelial cell proliferation (GO:0033600)|nucleotide-excision repair (GO:0006289)|oocyte maturation (GO:0001556)|positive regulation of mitotic cell cycle (GO:0045931)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cytokinesis (GO:0032465)|replication fork protection (GO:0048478)|response to gamma radiation (GO:0010332)|response to UV-C (GO:0010225)|response to X-ray (GO:0010165)|spermatogenesis (GO:0007283)",BRCA2-MAGE-D1 complex (GO:0033593)|centrosome (GO:0005813)|cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|protein complex (GO:0043234)|secretory granule (GO:0030141),gamma-tubulin binding (GO:0043015)|H3 histone acetyltransferase activity (GO:0010484)|H4 histone acetyltransferase activity (GO:0010485)|protease binding (GO:0002020)|single-stranded DNA binding (GO:0003697),.,.,.,.,88,1,AX079
